BMJ Oncology (Aug 2024)

Recall of ibrutinib and issues with therapeutic approval

  • Alyson Haslam,
  • Colton Lipfert,
  • Myung Sun Kim,
  • Vinay K Prasad

DOI
https://doi.org/10.1136/bmjonc-2024-000418
Journal volume & issue
Vol. 3, no. 1

Abstract

Read online

No abstracts available.